Cytomegalovirus infection in pediatric solid organ transplant recipients and role of prophylaxis

被引：0
|
作者：
Nance, Gwen [1 ]
Serluco, Anastacia [1 ]
Deshpande, Shri [1 ,2 ]
Garro, Rouba [1 ,3 ]
George, Roshan [1 ,3 ]
Kelleman, Michael [3 ]
Yildrim, Inci [1 ,3 ]
Liverman, Rochelle [1 ]
机构：
[1] Childrens Healthcare Atlanta, Atlanta, GA USA
[2] Sibley Heart Ctr Cardiol, Atlanta, GA USA
[3] Emory Univ, Atlanta, GA 30322 USA
来源：
PEDIATRIC TRANSPLANTATION | 2019年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P.243
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prophylaxis of hepatitis B infection in solid organ transplant recipients
    John, Savio
    Andersson, Karin L.
    Kotton, Camille N.
    Hertl, Martin
    Markmann, James F.
    Cosimi, A. Benedict
    Chung, Raymond T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (04) : 309 - 319
  • [22] Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients
    Flynn, JT
    Kaiser, BA
    Long, SS
    Schulman, SL
    Deforest, A
    Polinsky, MS
    Baluarte, HJ
    AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (02) : 146 - 152
  • [23] PROPHYLAXIS OF CYTOMEGALOVIRUS (CMV) DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW
    Ladhani, M.
    Hodson, E. M.
    Webster, A. C.
    Strippoli, G. F. M.
    Craig, J. C.
    NEPHROLOGY, 2012, 17 : 68 - 68
  • [24] Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients
    Torres-Madriz, Gilberto
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (05) : 702 - 711
  • [25] Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients
    Cochrane, Adam B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S17 - S21
  • [26] Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients
    Cochrane, Adam B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S17 - S21
  • [27] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
    Fellay, J
    Venetz, JP
    Pascual, M
    Aubert, JD
    Seydoux, C
    Meylan, PR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) : 1781 - 1782
  • [28] Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients
    Foca, Marc
    Demirhan, Salih
    Munoz, Flor M.
    Deray, Kristen G. Valencia
    Bocchini, Claire E.
    Sharma, Tanvi S.
    Sherman, Gilad
    Muller, William J.
    Heald-Sargent, Taylor
    Danziger-Isakov, Lara
    Blum, Samantha
    Boguniewicz, Juri
    Bacon, Samantha
    Joseph, Tuhina
    Smith, Jodi
    Ardura, Monica, I
    Su, Yin
    Maron, Gabriela M.
    Ferrolino, Jose
    Herold, Betsy C.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [29] Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients
    Rowshani, AT
    Bemelman, FJ
    van Leeuwen, EMM
    van Lier, RAW
    ten Berge, IJM
    TRANSPLANTATION, 2005, 79 (04) : 381 - 386
  • [30] Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
    Razonable, Raymund R.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2013, 27 (02) : 317 - +
12345